Dechtman Wealth Management’s AbbVie ABBV Stock Holding History

Dechtman Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$782K	Buy	4,400 +30	+0.7%	+$5.52K	0.15%	23
2024 Q3	$863K	Buy	4,370 +389	+10%	+$72.6K	0.18%	24
2024 Q2	$683K	Sell	3,981 -133	-3%	-$22K	0.15%	26
2024 Q1	$749K	Buy	4,114 +35	+0.9%	+$6.03K	0.17%	27
2023 Q4	$632K	Buy	4,079 +44	+1%	+$6.42K	0.17%	25
2023 Q3	$602K	Sell	4,035 -762	-16%	-$112K	0.18%	25
2023 Q2	$646K	Buy	+4,797	New	+$703K	0.19%	24

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dechtman Wealth Management's ABBV Position: Q4 2024 in Review

Dechtman Wealth Management increased its AbbVie (ABBV) stake by 0.69% in Q4 2024, buying an estimated $5.52K and bringing the position to 4,400 shares worth $782K. The position accounts for 0.15% of the portfolio, ranked #23.

Dechtman Wealth Management first reported a position in ABBV in Q2 2023 and has held it in 7 quarters since. The position peaked at $863K in Q3 2024. 3,750 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

Dechtman Wealth Management held 4,400 shares of AbbVie worth $782K as of Q4 2024.
Dechtman Wealth Management bought 30 AbbVie shares in Q4 2024, an estimated $5.52K.
AbbVie made up 0.15% of Dechtman Wealth Management's portfolio in Q4 2024, its #23 holding.
Dechtman Wealth Management first reported a position in AbbVie in Q2 2023 and has held it in 7 quarters since.
Dechtman Wealth Management's AbbVie position peaked at $863K in Q3 2024.
3,750 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Dechtman Wealth Management's 13F filing for Q4 2024, filed 12 Feb 2025.